Immix Biopharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $104.8M
Liabilities Breakdown FY2025
Total Liabilities: $11.0M
Asset Breakdown
Total Assets: $104.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $93.9M | 89.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.5M | 2.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $8.4M | 8.0% |
Liabilities Breakdown
Total Liabilities: $11.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.4M | 49.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $5.6M | 50.7% |